{"url_path":"/sec/cvkd/8-k/2026-06-29/item-9-01","section_key":"item-9-01","section_title":"Item 9.01 Financial Statements and Exhibits.**","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-06-29","source_url":"https://www.sec.gov/Archives/edgar/data/1937993/0001213900-26-073213-index.html","accession_number":"0001213900-26-073213","cik":"0001937993","ticker":"CVKD","issuer_name":"Cadrenal Therapeutics, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1937993/0001213900-26-073213-index.html","primary_entity_key":"0001937993","primary_entity_name":"Cadrenal Therapeutics, Inc."},"word_count":131,"has_tables":true,"body_markdown":"**Item 9.01 Financial Statements and Exhibits.**\n\n \n\n(d) Exhibits\n\n \n\nThe following\nexhibits are furnished with this Current Report on Form 8-K:\n\n \n\n**Exhibit\nNumber**\n \n**Exhibit Description**\n\n10.1\n \n[Master Services Agreement, dated August 21, 2024, between the Company and Lohman & Associates, Inc.](ea029632801ex10-1.htm)\n\n10.2\n \n[Statement of Work Number Five, effective as of June 25, 2026, pursuant to Master Services Agreement](ea029632801ex10-2.htm)\n\n104\n \nCover Page Interactive Data File (the cover page XBRL tags are embedded within in the inline XBRL document)\n\n \n\n2\n\n \n\n \n\n**SIGNATURES**\n\n \n\nPursuant to the requirements of the Securities\nExchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.\n\n \n\nDated: June 29, 2026\n**CADRENAL THERAPEUTICS, INC.**\n\n \n \n\n \nBy:\n/s/ Quang X. Pham\n\n \nName:\nQuang X. Pham\n\n \nTitle:\nChairman and Chief Executive Officer\n\n \n\n3"}